258 related articles for article (PubMed ID: 33968069)
1. Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Sáez Moya M; Gutiérrez-Cózar R; Puñet-Ortiz J; Rodríguez de la Concepción ML; Blanco J; Carrillo J; Engel P
Front Immunol; 2021; 12():666545. PubMed ID: 33968069
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis reveals isotype-specific autoreactive B cell repertoires in Sjögren's syndrome.
Nguyen CQ; Ogunniyi AO; Karabiyik A; Love JC
PLoS One; 2013; 8(3):e58127. PubMed ID: 23516437
[TBL] [Abstract][Full Text] [Related]
3. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
Front Immunol; 2018; 9():2661. PubMed ID: 30519241
[TBL] [Abstract][Full Text] [Related]
4. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
5. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
Karnell JL; Mahmoud TI; Herbst R; Ettinger R
Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
[TBL] [Abstract][Full Text] [Related]
6. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
7. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
8. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.
Robinson CP; Brayer J; Yamachika S; Esch TR; Peck AB; Stewart CA; Peen E; Jonsson R; Humphreys-Beher MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7538-43. PubMed ID: 9636185
[TBL] [Abstract][Full Text] [Related]
9. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
[TBL] [Abstract][Full Text] [Related]
10. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
11. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
12. Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.
Witas R; Rasmussen A; Scofield RH; Radfar L; Stone DU; Grundahl K; Lewis D; Sivils KL; Lessard CJ; Farris AD; Nguyen CQ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575873
[TBL] [Abstract][Full Text] [Related]
13. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
15. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
16. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
17. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndrome.
Broeren MGA; Wang JJ; Balzaretti G; Groenen PJTA; van Schaik BDC; Chataway T; Kaffa C; Bervoets S; Hebeda KM; Bounova G; Pruijn GJM; Gordon TP; De Vries N; Thurlings RM
Ann Rheum Dis; 2022 May; 81(5):644-652. PubMed ID: 35144926
[TBL] [Abstract][Full Text] [Related]
19. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.
Braley-Mullen H; Yu S
Adv Immunol; 2015; 126():1-43. PubMed ID: 25727287
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model.
Killian M; Colaone F; Haumont P; Nicco C; Cerles O; Chouzenoux S; Cathébras P; Rochereau N; Chanut B; Thomas M; Laroche N; Forest F; Grouard-Vogel G; Batteux F; Paul S
Front Immunol; 2021; 12():666134. PubMed ID: 34867938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]